耳鼻咽喉科・頭頸部外科94巻8号

2022年07月発行

特集 ウイルス感染症に強くなる！—予防・診断・治療のポイント

《各論》

ヒト乳頭腫ウイルスと関連腫瘍

著者： 鈴木幹男¹ 平川仁¹

所属機関： ¹琉球大学耳鼻咽喉・頭頸部外科学講座

ページ範囲：P.655 - P.659

文献概要

POINT

●ヒト乳頭腫ウイルス（HPV）は頭頸部領域から広く検出される。

●良性疾患では，喉頭乳頭腫を生じる。

●悪性疾患では，HPV関連中咽頭癌（特に側壁，前壁）を生じる。

●予防ワクチンは3種類あり，積極的な勧奨が差し控えられていたのが終了し，2022年4月から個別に定期接種の通知が発送されている。

参考文献

1）IARC Working Group on the Evaluation of Carcinogenic Risks to Humans：IARC monographs on the evaluation of carcinogenic risks to humans. vol. 90. Human papillomaviruses. International Agency for Research on Cancer, Lyon, 2007, pp45-355

2）Dürst M, et al：A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci U S A 80：3812-3815, 1983

3）鈴木幹男・他：疫学と病態—中咽頭癌と子宮頸癌のHPVの違いは？　JOHNS 32：287-292，2016

4）Deng Z, et al：A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma. Int J Oncol 45：67-76, 2014

5）Yamashita Y, et al：Human papillomavirus infection and immunohistochemical expression of cell cycle proteins pRb, p53, and p16（INK4a）in sinonasal diseases. Infect Agent Cancer 10：23, 2015

6）Kreimer AR, et al：Oral human papillomavirus in healthy individuals：a systematic review of the literature. Sex Transm Dis 37：386-391, 2010

7）Tang KD, et al：Oral HPV16 DNA as a screening tool to detect early oropharyngeal squamous cell carcinoma. Cancer Sci 111：3854-3861, 2020

8）Ikegami T, et al：Development of antibodies against HPV-6 and HPV-11 for the study of laryngeal papilloma. Viruses 13：2024, 2021

9）Deng Z, et al：Methylation of CpG sites in the upstream regulatory region, physical status and mRNA expression of HPV-6 in adult-onset laryngeal papilloma. Oncotarget 8：85368-85377, 2017

10）Syrjänen K, et al：Detection of human papillomavirus in sinonasal papillomas：systematic review and meta-analysis. Laryngoscope 123：181-192, 2013

11）Isayeva T, et al：Human papillomavirus in non-oropharyngeal head and neck cancers：a systematic literature review. Head Neck Pathol 6（Suppl 1）：S104-S120, 2012

12）Liu H, et al：Human papillomavirus as a favorable prognostic factor in a subset of head and neck squamous cell carcinomas：a meta-analysis. J Med Virol 89：710-725, 2017

13）金城秀俊・他：HPV関連中咽頭癌（p16陽性）死亡例の検討．頭頸部癌45：397-402，2019

14）Gillison ML, et al：Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer（NRG Oncology RTOG 1016）：a randomised, multicentre, non-inferiority trial. Lancet 393：40-50, 2019

15）Mehanna H, et al：Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer（De-ESCALaTE HPV）：an open-label randomised controlled phase 3 trial. Lancet 393：51-60, 2019

16）Misiukiewicz K, et al：Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV＋ oropharyngeal carcinoma patients：the Quarterback trial. Oral Oncol 95：170-177, 2019

17）Rosenberg AJ, et al：Optimizing treatment de-escalation in head and neck cancer：current and future perspectives. Oncologist 26：40-48, 2021

18）Galvin AM, et al：Health literacy correlates to HPV vaccination among US adults ages 27-45. J Cancer Educ, 2022〔Online ahead of print〕　doi：10.1007/s13187-021-02123-x

19）Domingos-Pereira S, et al：Vaccination with a nanoparticle E7 vaccine can prevent tumor recurrence following surgery in a human papillomavirus head and neck cancer model. Oncoimmunology 10：1912473, 2021

20）Hasan Y, et al：A phase 1 trial assessing the safety and tolerability of a therapeutic DNA vaccination against HPV16 and HPV18 E6/E7 oncogenes after chemoradiation for cervical cancer. Int J Radiat Oncol Biol Phys 107：487-498, 2020

21）Drolet M, et al：Population-level impact and herd effects following human papillomavirus vaccination programmes：a systematic review and meta-analysis. Lancet Infect Dis 15：565-580, 2015

22）Arbyn M, et al：Efficacy and safety of prophylactic HPV vaccines. A Cochrane review of randomized trials. Expert Rev Vaccines 17：1085-1091, 2018

23）Yagi A, et al：A nationwide birth year-by-year analysis of effectiveness of HPV vaccine in Japan. Cancer Sci 112：3691-3698, 2021